terfenadine has been researched along with glycoprotein e2, hepatitis c virus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht, B; Bartenschlager, R; Hartmann, RW; Holzer, M; Kattner, L; Kaul, A; Klein, CD; Kronenberger, B; Ziegler, S | 1 |
1 other study(ies) available for terfenadine and glycoprotein e2, hepatitis c virus
Article | Year |
---|---|
Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization.
Topics: Acylation; Antibodies, Viral; Antigens, CD; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Neutralization Tests; Protein Binding; Structure-Activity Relationship; Terfenadine; Tetraspanin 28; Viral Envelope Proteins; Virion | 2008 |